cj red bio anticancer drug
Scope
Date
~
-
Corporate investment
CJ to beef up content, K-food sector with $9.7 billion investment
South Korea’s CJ Group, which operates the country’s largest food and beverage company CJ Cheiljedang Corp. and entertainment giant CJ E...
May 30, 2022 (Gmt+09:00)
language -
Behind the Scenes
Samsung in do-or-die race with $355 bn spending plan
"It's not a matter of numbers, but a matter of do or die for us."This is the first public remark from Samsung Electronics Co. Vice Chairman and de f...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
SK takes aim at chips, batteries, bio with $195 billion investment
SK Group, South Korea’s second-largest conglomerate after Samsung, on Thursday announced a plan to invest 247 trillion won ($195 billion) in k...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
Bio, mobility to top Lotte's $30 bn spending list by 2026
South Korea’s Lotte Group will spend a total of 37 trillion won ($29 billion) on its businesses over the next five years, a chunk of which wil...
May 25, 2022 (Gmt+09:00)
language -
Corporate investment
Samsung to invest $355 billion in chip, biotech, 6G over five years
South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...
May 24, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Entertainment
CJ ENM, Naver to launch drama studio joint venture in Japan
South Korean entertainment powerhouse CJ ENM Co. and online platform giant Naver Corp. are launching a drama production studio in Japan to tap into ...
May 12, 2022 (Gmt+09:00)
-
Carbon neutrality
Hyundai Oilbank steps up eco-friendly white bio business
Hyundai Oilbank Co., a South Korean petroleum and refinery company, is slated to tap into the white biotechnology market. The company has selected w...
May 11, 2022 (Gmt+09:00)
-
Korean startups
CJ ventures into fandom platform with $17 mn investment
CJ Group, one of South Korea’s largest family run conglomerates, or chaebol, is venturing into the fandom platform business with a 22.4 billio...
May 11, 2022 (Gmt+09:00)
-
Pension funds
POBA targets PE in tech, bio, healthcare in long term, CIO says
Public Officials Benefit Association (POBA) of South Korea will keep its focus on steady cash flow while strengthening profitability, its Chief Inve...
May 09, 2022 (Gmt+09:00)
-
Metaverse
CJ ENM buys stake in US metaverse firm Hyperreal
South Korean entertainment powerhouse CJ ENM Co. has acquired a minority stake in US metaverse entertainment and media firm Hyperreal Digital Inc., ...
May 03, 2022 (Gmt+09:00)
language -
IPOs
Korea’s tough IPO review drives bio startup to Nasdaq
A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...
Apr 22, 2022 (Gmt+09:00)
-
Korean food
CJ steps up US exports with new instant rice bowls
South Korea's food and beverage giant CJ CheilJedang Corp. on April 21 began shipment of its new Hetbahn instant rice products for US consumers from...
Apr 21, 2022 (Gmt+09:00)
-
Artificial intelligence
CJ integrates AI infrastructure and data to launch CJ AI center
CJ Corp. launched an artificial intelligence center Wednesday, which it hopes will lead the conglomerate's digital innovation. The new CJ AI Cente...
Apr 21, 2022 (Gmt+09:00)
-
Samsung Group
CJ, Samsung to launch $600 million e-commerce logistics fund
CJ Logistics and an affiliate of Samsung Life Insurance have joined forces to launch a real estate investment fund worth 740 billion won ($600 milli...
Apr 18, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Entertainment
CJ ENM sets up production studio focused on OTT content
South Korea’s entertainment giant CJ ENM Co. established a studio specializing in content for over-the-top (OTT) platforms at home and abroad ...
Apr 06, 2022 (Gmt+09:00)
language -
Corporate strategy
SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors
South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...
Mar 28, 2022 (Gmt+09:00)
language -
Entertainment
CJ ENM drops split-off plan; to set up new film studio
CJ ENM Co., South Korea’s entertainment giant, has dropped a plan to carve out its content production business into a new unit in the face of ...
Mar 25, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
CJ ENM to invest $82 million in KT to strengthen OTT partnership
South Korean entertainment powerhouse CJ ENM Co. said on Monday it will invest 100 billion won ($82.3 million) in KT Studio Genie, a content produ...
Mar 21, 2022 (Gmt+09:00)
-
IPOs
Korean IPOs delayed after bourse's sweeping reshuffle
Scores of South Korean initial public offerings slated for the first half of this year have been delayed after the bourse operator carried out a lar...
Mar 17, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Upcoming IPOs
Korea’s Voronoi in talks with global firms on drug designs
South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...
Mar 04, 2022 (Gmt+09:00)
-
Private equity
Korean SPAC Valuence Merger debuts on Nasdaq, targets bio M&As
Valuence Merger Corp. 1, a special purpose acquisition company (SPAC), led by South Korean fund managers, has debuted on the Nasdaq, targeting Asian...
Mar 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio ventures struggle with fundraising
Biopharmaceutical companies of South Korea are having a tough time fundraising of late. Bio ventures without specific public offering plans are pa...
Mar 01, 2022 (Gmt+09:00)
-
Entertainment
CJ ENM’s streaming platform raises $209 mn to finance original content
TVing Co. is poised to sell 382,513 new shares to South Korean private equity fund JC Partner Co.’s affiliate to raise 250 billion won ($209 m...
Feb 18, 2022 (Gmt+09:00)
-
Corporate restructuring
CJ ENM shelves content split-off plan; shares rise
South Korean entertainment powerhouse CJ ENM Co. has put its plan to split off its content business on the shelf in the face of growing opposition f...
Feb 09, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Netmarble shares slide on report of CJ ENM's stake sale plan
Shares in South Korea's leading game developer Netmarble Corp. plunged 8.7% on Thursday to end at its lowest level in more than one and a half years...
Feb 03, 2022 (Gmt+09:00)
-
Corporate restructuring
SK's 5-year journey toward batteries, bio and chips
Back in January 2017, SK Group Chairman Chey Tae-won emphasized the need for “deep change," in his New Year message and presented the phrase a...
Jan 23, 2022 (Gmt+09:00)
Latest News
- 1 Jollibee to buy chicken chain Norang Tongdak amid K-food frenzy
- 2 Micron set to supply SOCAMM chips to Nvidia ahead of Samsung, SK Hynix
- 3 POSCO Future M breaks with China in cathode supply chain
- 4 GIC resumes Seoul Finance Center sale in potential megadeal
- 5 South Korea’s Lee, China’s Xi agree on closer ties, peace on Korean Peninsula